Consider Recommending a Beta-Blocker for Surgery in High-Risk Patients

New guidelines will clarify when to use beta-blockers for noncardiac surgery.

Beta-blockers reduce the risk of nonfatal heart attack in high-risk patients undergoing noncardiac surgery...probably by decreasing cardiac workload.

But this benefit can come at a cost...bradycardia, hypotension, and possibly a higher risk of stroke and death.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote